logo
Select company
Select metric
$ -92.48MEarning Before Interest & Taxes (EBIT)
VS
Market
10
Sector
22
Industry
31
History
14
$ 2.86Close
$ 1.42 - $ 24.24 52-Week Range
Ticker Information

Ticker

XFOR

Company Name

X4 PHARMACEUTICALS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

X4 PHARMACEUTICALS INC - Earning Before Interest & Taxes (EBIT) Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

XFOR - EBIT Historical data
DateEarning Before Interest & Taxes (EBIT)
6/30/2025$ -92.48M
3/31/2025$ 24.02M
12/31/2024$ -28.37M
9/30/2024$ -8.32M
6/30/2024$ 25.3M
3/31/2024$ -122.28M
12/31/2023$ -95.31M
9/30/2023$ -106.05M
6/30/2023$ -125.98M
3/31/2023$ -91.72M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • X4 PHARMACEUTICALS INC's latest trailing twelve months (TTM) EBIT stands at $ -51.9M.
  • Over the past 5 years, X4 PHARMACEUTICALS INC's average EBIT has been $ -69.38M.
  • The median EBIT for X4 PHARMACEUTICALS INC during this period was $ -86.66M
  • X4 PHARMACEUTICALS INC reached its highest EBIT over the past 5 years at $ 25.3M.
  • The lowest EBIT recorded by X4 PHARMACEUTICALS INC in the same timeframe $ -125.98M

X4 PHARMACEUTICALS INC's EBIT vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBIT Benchmarks
CompanyEBIT
AMS : AMERICAN SHARED HOSPITAL SERVICES $ -1.38MBNGO : BIONANO GENOMICS INC $ -74.29MCRIS : CURIS INC $ -38.92MMRKR : MARKER THERAPEUTICS INC $ -14.56MLPCN : LIPOCINE INC $ -4.51MDRIO : DARIOHEALTH CORP $ -44.02MGBIO : GENERATION BIO CO $ -72.42MBCAB : BIOATLA INC $ -59.52MCARM : CARISMA THERAPEUTICS INC $ -49.38MHOTH : HOTH THERAPEUTICS INC $ -10.19M

Definition of Earning Before Interest & Taxes (EBIT)

[Income Statement] Earnings before interest and taxes measures a company's net income [NetInc] prior to the deduction of interest [IntExp] and tax expenses [TaxExp].

XFOR - Earning Before Interest & Taxes (EBIT), Last 5 years

$ -125.98M

Minimum

Jun 30, 2023

$ 25.3M

Maximum

Jun 30, 2024

$ -69.38M

Average

$ -86.66M

Median

EBIT Benchmark Analysis

The chart above depicts the distribution of EBIT for companies in the Total Stock Market. The average EBIT of the companies is $ 28.48M with a standard deviation of $ 130.48M.
The following table provides additional summary stats:
EBIT in the Market:
filtered constituents3.29K
min$ -402.08M
max$ 442M
average$ 28.48M
median$ 847.86K
std$ 130.48M